1. Home
  2. BCAL vs MBX Comparison

BCAL vs MBX Comparison

Compare BCAL & MBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAL
  • MBX
  • Stock Information
  • Founded
  • BCAL 2001
  • MBX 2018
  • Country
  • BCAL United States
  • MBX United States
  • Employees
  • BCAL N/A
  • MBX N/A
  • Industry
  • BCAL Major Banks
  • MBX
  • Sector
  • BCAL Finance
  • MBX
  • Exchange
  • BCAL Nasdaq
  • MBX NYSE
  • Market Cap
  • BCAL 460.6M
  • MBX 381.4M
  • IPO Year
  • BCAL N/A
  • MBX 2024
  • Fundamental
  • Price
  • BCAL $16.20
  • MBX $13.29
  • Analyst Decision
  • BCAL Strong Buy
  • MBX Strong Buy
  • Analyst Count
  • BCAL 1
  • MBX 5
  • Target Price
  • BCAL $20.00
  • MBX $37.40
  • AVG Volume (30 Days)
  • BCAL 121.6K
  • MBX 347.0K
  • Earning Date
  • BCAL 07-28-2025
  • MBX 08-16-2025
  • Dividend Yield
  • BCAL N/A
  • MBX N/A
  • EPS Growth
  • BCAL N/A
  • MBX N/A
  • EPS
  • BCAL 0.62
  • MBX N/A
  • Revenue
  • BCAL $132,045,000.00
  • MBX N/A
  • Revenue This Year
  • BCAL $74.16
  • MBX N/A
  • Revenue Next Year
  • BCAL $4.92
  • MBX N/A
  • P/E Ratio
  • BCAL $25.96
  • MBX N/A
  • Revenue Growth
  • BCAL 42.63
  • MBX N/A
  • 52 Week Low
  • BCAL $11.87
  • MBX $4.81
  • 52 Week High
  • BCAL $18.49
  • MBX $27.50
  • Technical
  • Relative Strength Index (RSI)
  • BCAL 68.44
  • MBX N/A
  • Support Level
  • BCAL $14.07
  • MBX N/A
  • Resistance Level
  • BCAL $16.75
  • MBX N/A
  • Average True Range (ATR)
  • BCAL 0.47
  • MBX 0.00
  • MACD
  • BCAL 0.09
  • MBX 0.00
  • Stochastic Oscillator
  • BCAL 81.63
  • MBX 0.00

About BCAL Southern California Bancorp

California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through partnerships with its clients. The company has one operating segment: Commercial Banking.

About MBX MBX BIOSCIENCES INC

MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.

Share on Social Networks: